Between 2021 and 2022, adverse events fell the most across the following three areas: Ventilator-associated events went down by 19%, hospital-onset methicillin-resistant Staphylococcus aureus infections fell 16% and catheter-associated urinary tract infections fell by 12%.
Progress was also made in the decrease of central line-associated blood infections, which declined by 9%, and hospital-onset Clostridioides difficile, which fell 3%, according to the report, which was released in November.
“Under the leadership of healthcare epidemiologists and infection preventionists, acute care facilities have made substantial progress in shifting attention that was understandably focused on responding to the COVID-19 pandemic back to broader infection prevention initiatives that protect our patients from a wide range of infections,” Deborah Yokoe, MD, president of the Society for Healthcare Epidemiology of America, said in a statement shared with Becker’s.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
